Dendritic cell vaccination as a treatment modality for mesothelioma
Author:
- 1 June 2010
- journal article
- Published by Taylor & Francis in Expert Review of Respiratory Medicine
- Vol. 4 (3) , 311-314
Abstract
(2010). Dendritic cell vaccination as a treatment modality for mesothelioma. Expert Review of Respiratory Medicine: Vol. 4, No. 3, pp. 311-314. doi: 10.1586/ers.10.33Keywords
This publication has 18 references indexed in Scilit:
- What's the place of immunotherapy in malignant mesothelioma treatments?Cell Adhesion & Migration, 2010
- Dendritic Cell Preparation for Immunotherapeutic InterventionsImmunotherapy, 2009
- Dendritic Cells in Cancer Immunotherapy2008
- Recombinant GM-CSF plus autologous tumor cells as a vaccine for patients with mesotheliomaLung Cancer, 2006
- Prognostic factors in mesotheliomaLung Cancer, 2005
- Immunotherapy of Murine Malignant Mesothelioma Using Tumor Lysate–pulsed Dendritic CellsAmerican Journal of Respiratory and Critical Care Medicine, 2005
- Dendritic cells as therapeutic vaccines against cancerNature Reviews Immunology, 2005
- Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural MesotheliomaJournal of Clinical Oncology, 2003
- Anti-cancer therapy using dendritic cells and apoptotic tumour cells: pre-clinical data in human mesothelioma and acute myeloid leukaemiaVaccine, 2003
- Malignant pleural mesotheliomaEuropean Respiratory Journal, 1998